(ASND) Ascendis Pharma complete technical analysis [charts+indicators] | Buy/Sell Ascendis Pharma | (ASND) share price targets
Complete technical analysis of Ascendis Pharma (ASND) by charts plus indicators, forecast predictions and share price targets for Ascendis Pharma (ASND)
Ascendis Pharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-12-31 View latest technical analysis
10 day averaged volume of Ascendis Pharma is 321726
Date | Daily Closing Price | Open | High | Low | Volume |
31 Tue Dec 2024 | 137.62 | 138.00 | 138.00 | 134.71 | 0.611 times |
30 Mon Dec 2024 | 136.48 | 136.33 | 138.47 | 134.49 | 0.587 times |
27 Fri Dec 2024 | 137.50 | 139.39 | 141.25 | 137.26 | 0.512 times |
26 Thu Dec 2024 | 140.31 | 138.45 | 141.47 | 136.90 | 0.373 times |
24 Tue Dec 2024 | 138.79 | 139.70 | 140.22 | 136.34 | 0.224 times |
23 Mon Dec 2024 | 139.70 | 137.28 | 140.47 | 135.61 | 0.489 times |
20 Fri Dec 2024 | 136.38 | 137.00 | 141.37 | 135.61 | 1.964 times |
19 Thu Dec 2024 | 137.74 | 136.53 | 139.39 | 134.53 | 1.507 times |
18 Wed Dec 2024 | 135.70 | 140.35 | 140.70 | 135.02 | 1.116 times |
17 Tue Dec 2024 | 140.30 | 136.60 | 141.48 | 136.03 | 1.757 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 138.7 as stoploss in an intra day sell trade for a target of 135.21. However, stock will show a bullish move above 138.7.
Share price targets for Ascendis Pharma (ASND)
Target Type | Value |
Downside Target | 111.09 |
Downside Target | 118.05 |
Downside Target | 126.74 |
Downside Target | 134.49 |
Downside Target | 135.71 |
Upside Target | 138.47 |
Upside Target | 141.47 |
Upside Target | 141.48 |
Upside Target | 144.62 |
Upside Target | 149.31 |
Upside Target | 155.53 |
Intraday share price targets for Ascendis Pharma (ASND)
Target Type | Value |
Downside Intraday Target | 135.25 |
Downside Intraday Target | 132.88 |
Upside Intraday Target | 139.23 |
Upside Intraday Target | 140.84 |
Downside Intraday Target | 136.86 |
Weekly technical analysis of Ascendis Pharma (ASND)
Date | Weekly Closing Price | Open | High | Low | Volume |
31 Tue Dec 2024 | 137.62 | 136.33 | 138.47 | 134.49 | 0.749 times |
27 Fri Dec 2024 | 137.50 | 137.28 | 141.47 | 135.61 | 0.204 times |
20 Fri Dec 2024 | 136.38 | 130.13 | 141.48 | 130.00 | 2.11 times |
13 Fri Dec 2024 | 129.87 | 132.60 | 135.71 | 126.74 | 2.346 times |
26 Tue Nov 2024 | 134.60 | 131.42 | 134.71 | 128.63 | 0.474 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Ascendis Pharma (ASND)
Date | Monthly Closing Price | Open | High | Low | Volume |
31 Tue Dec 2024 | 137.62 | 132.60 | 141.48 | 126.74 | 0.452 times |
26 Tue Nov 2024 | 134.60 | 124.04 | 134.71 | 118.05 | 1.124 times |
31 Thu Oct 2024 | 122.82 | 149.31 | 149.31 | 120.77 | 0.407 times |
30 Mon Sep 2024 | 149.31 | 136.41 | 155.53 | 111.09 | 2.447 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Ascendis Pharma (ASND)
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Ascendis Pharma in short term and the buy signal is strong.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 137.82 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Ascendis Pharma ( (ASND) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Ascendis Pharma ( (ASND) ) based on a mid to longer term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
ADX buy sell signal for Ascendis Pharma stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a BUY signal for Ascendis Pharma in short term and the buy signal is strong.
Ascendis Pharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be moving up
CCI has generated a buy signal for Ascendis Pharma in short term but BUY signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Ascendis Pharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 137.82 and Ascendis Pharma (ASND) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Ascendis Pharma (ASND) stock. Volume based technical analysis of Ascendis Pharma (ASND) stock is negative.
Ascendis Pharma Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.